Friday, July 31, 2026

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

Seoul’s Calm-Response Strategy: As Tariffs Loom at 25%, Can Korea Keep the U.S. Deal at 15%?

Yeo Han Ku reassures calm amid Trump's tariff threats, emphasizing South Korea's commitment to trade relations and national interests.

Two Indonesian Technicians Dispatched to KAI Investigated for Attempting to Leak KF-21 Technology

The police have launched a forced investigation...

Tag: attire

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.